本文關鍵詞： 胃癌 型糖尿病 手術治療　出處：《中國實用外科雜志》2017年02期 　論文類型：期刊論文

【摘要】：目的探討影響胃癌合并2型糖尿病(T2DM)病人術后糖尿病改善的相關因素。方法回顧性分析2013年1月至2016年7月第二軍醫(yī)大學附屬長海醫(yī)院162例胃癌合并T2DM病人臨床及隨訪資料,包括性別、年齡、糖尿病病程、隨訪術后血糖變化及用藥情況,腫瘤大小、分型、分期、浸潤深度、淋巴轉移情況,以及胃癌根治手術不同手術方式治療(Bypass-:BillrothⅠ式吻合、近端胃切除;Bypass+:全胃或遠端胃切除+Roux-en-Y吻合),采用CMH及秩和檢驗進行單因素分析,并對相關因素進行l(wèi)ogistic回歸分析。結果胃癌合并T2DM病人術后效果與病人年齡、腫瘤大小、手術方式及病程長短存在明顯相關性。而與病人性別、術后血糖變化及用藥情況、腫瘤分型、分期、浸潤深度、淋巴轉移情況指數(shù)無明顯相關性。結論對于胃癌合并T2DM病人,Bypass+有助于改善胃癌術后病人血糖,特別是T2DM病程較短、年齡較小、腫瘤較小病人,以此提高術后短期內(nèi)糖尿病改善。
[Abstract]:Objective to investigate the effect of T2DM on gastric cancer complicated with type 2 diabetes mellitus (T2DM). Methods the clinical and follow-up data of 162 patients with gastric cancer complicated with T2DM in Changhai Hospital affiliated to the second military Medical University from January 2013 to July 2016 were retrospectively analyzed. . These included sex, age, course of diabetes, changes in blood glucose and medication, tumor size, classification, staging, depth of invasion, lymphatic metastasis after follow-up. And different surgical methods of radical gastrectomy were used to treat Bypass-proportion Billroth 鈪，

本文編號：1490409